NewsRx

Search our medical news database

Personnel

Replidyne's Glenn Tillotson elected a Fellow of the American College of Chest Physicians

Published in Healthcare Mergers, Acquisitions and Ventures Week, December 9th, 2006

Replidyne, Inc. (RDYN) announced that its executive director of Scientific Affairs, Glenn Tillotson, PhD, has been elected a fellow of the American College of Chest Physicians.

Tillotson is the only nonmedical doctor from industry to be inducted into the College.

Tillotson joined Replidyne in April 2006 with nearly 20 years comprehensive pharmaceutical experience, mainly in the field of anti-infectives. While with Bayer Pharmaceuticals, Tillotson was instrumental in the development of ciprofloxacin and moxifloxacin. After leaving Bayer, he served as a consultant, helping to form biotech company Oscient following the merger of Genesoft and Genome...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook